NFKB1 and plasma cell myeloma: Our group recently tested this hypothesis in the context of multiple myeloma, a malignancy of plasma cells (PC) responsible for almost 2% of all cancer deaths and representing the paradigm of NF-κB-driven cancers (Annunziata et al., 2007; Keats et al., 2007).